Astrocyte Pharmaceuticals secures $9.5 million in Series B funding to advance Phase 2 clinical development of its breakthrough TBI and concussion therapy AST-004.
Amount Raised
$9.5 Million
Round Type
Series B
Description
Astrocyte Pharmaceuticals has successfully secured $9.5 million in a Series B funding round. The capital will be utilized to advance the Phase 2 clinical development of its innovative therapy for TBI and concussion, named AST-004. This funding will enable the company to conduct crucial trials and further validate its therapeutic approach. The investment underscores the potential impact of AST-004 in addressing significant unmet medical needs in brain injury treatment.
Quick answer
Astrocyte Pharmaceuticals Inc. raised $9.5 Million in a Series B round, dated September 30, 2026. Astrocyte Pharmaceuticals Inc. is based in Groton, Connecticut, United States.
- How much did Astrocyte Pharmaceuticals Inc. raise?
- Astrocyte Pharmaceuticals Inc. raised $9.5 Million in a Series B round on September 30, 2026.
- What does Astrocyte Pharmaceuticals Inc. do?
- Astrocyte Pharmaceuticals is a drug discovery and development company dedicated to accelerating the recovery and well-being of brain injury patients.
- Where is Astrocyte Pharmaceuticals Inc. based and how big is it?
- Astrocyte Pharmaceuticals Inc. is based in Groton, Connecticut, United States. Fundz records about 2 employees.
- Who are the decision-makers at Astrocyte Pharmaceuticals Inc?
- Fundz holds 1 contact at Astrocyte Pharmaceuticals Inc., including the Vice President of Research. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Astrocyte Pharmaceuticals Inc. that raised within 45 days of this round, from Fundz verified event records.
- Francis Medical raised an undisclosed amount on November 12, 2026.
- XpertDox LLC raised $20M (Series A) on November 11, 2026.
- Zus Health raised $33M (Series B) on November 10, 2026.
- Silo Pharma raised $815K (Post-IPO Equity) on November 6, 2026.
- Annovis Bio raised $21M (Post-IPO Equity) on November 5, 2026.
- Equinox raised $1B on November 2, 2026.
Who to call at Astrocyte Pharmaceuticals Inc., and when
A new round usually means Astrocyte Pharmaceuticals Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Astrocyte Pharmaceuticals Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Astrocyte Pharmaceuticals Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Astrocyte Pharmaceuticals Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Astrocyte Pharmaceuticals Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAstrocyte Pharmaceuticals Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.